(Q45736204)

15 December 2017

Causality assessment of suspected virus transmission by human plasma products (English)

1 reference

15 December 2017

1 reference

Schosser R

1

1 reference

15 December 2017

Keller-Stanislawski B

series ordinal

2

1 reference

15 December 2017

Nübling CM

series ordinal

3

1 reference

15 December 2017

Löwer J

series ordinal

4

1 reference

15 December 2017

1 August 2001

1 reference

15 December 2017

1 reference

15 December 2017

41

1 reference

15 December 2017

8

1 reference

15 December 2017

1020-1029

1 reference

Safety aspects in the manufacturing of plasma-derived coagulation factor concentrates

15 December 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41081020.X

Viral safety of clotting factor concentrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41081020.X

Emerging issues in blood safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41081020.X

Partitioning of hepatitis C virus during Cohn-Oncley fractionation of plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41081020.X

Clinical evaluation of viral safety of coagulation factor VIII and IX concentrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41081020.X

Harmonisation in pharmacovigilance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41081020.X

Hepatitis C virus RNA in factor VIII concentrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41081020.X

Hepatitis C transmission associated with intravenous immunoglobulins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41081020.X

Hepatitis C virus RNA in tetanus intramuscular immune globulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41081020.X

Testing for HCV-RNA in commercial intravenous immunoglobulins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41081020.X

Detection and characterization of hepatitis C virus RNA in immune globulins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41081020.X

PCR detection of a low viral load in a prothrombin complex concentrate that transmitted hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41081020.X

HCV and organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41081020.X

Demonstration of viraemia patterns in haemophiliacs treated with hepatitis-C-virus-contaminated factor VIII concentrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41081020.X

Hepatitis A virus infections associated with clotting factor concentrate in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41081020.X

Transmission of hepatitis A to patients with hemophilia by factor VIII concentrates treated with organic solvent and detergent to inactivate viruses. The Italian Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41081020.X

Hepatitis C virus transmission by intravenous immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41081020.X

Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41081020.X

A new cluster of hepatitis A infection in hemophiliacs traced to a contaminated plasma pool

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41081020.X

Molecular epidemiology of an outbreak of infection with hepatitis C virus in recipients of anti-D immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41081020.X

A second outbreak of hepatitis C virus infection from anti-D immunoglobulin in Ireland

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41081020.X

Prevalence and changes in hepatitis C virus genotypes among multitransfused persons with hemophilia. The Multicenter Hemophilia Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41081020.X

Outbreak of acute hepatitis C following the use of anti-hepatitis C virus--screened intravenous immunoglobulin therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41081020.X

Sequential change of the hypervariable region of the hepatitis C virus genome in acute infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41081020.X

Natural hosts of hepatitis A virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41081020.X

Transmission of hepatitis B by immune serum globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41081020.X

The effect on the safety of intravenous immunoglobulin of testing plasma for antibody to hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41081020.X

Reduction in risk of hepatitis transmission by heat-treatment of a human Factor VIII concentrate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41081020.X

Insufficient inactivation of HIV-1 in human cryo poor plasma by beta-propiolactone: results from a highly accurate virus detection method

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41081020.X

Non-A, non-B hepatitis occurring in agammaglobulinaemic patients after intravenous immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41081020.X

Intravenous immunoglobulin prophylaxis causing liver damage in 16 of 77 patients with hypogammaglobulinemia or IgG subclass deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41081020.X

Gammagard and reported hepatitis C virus episodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41081020.X

Acute hepatitis A in haemophiliacs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41081020.X

Acute hepatitis A in patients with haemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41081020.X

Augmented tumour necrosis factor in Reye's syndrome associated with dengue virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41081020.X

Hepatitis A transmission by factor IX concentrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41081020.X

Removal/neutralization of hepatitis A virus during manufacture of high purity, solvent/detergent factor VIII concentrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41081020.X

More evidence on safety of intramuscular immune serum globulin produced from plasma unscreened for anti-hepatitis C virus antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41081020.X

Sexual transmission of the hepatitis C virus and efficacy of prophylaxis with intramuscular immune serum globulin. A randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41081020.X

Analysis of human plasma products: polymerase chain reaction does not discriminate between live and inactivated viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41081020.X

Non-A, non-B hepatitis from intravenous immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41081020.X

Causal or casual? The role of causality assessment in pharmacovigilance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41081020.X

Principles of signal detection in pharmacovigilance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41081020.X

Intravenous immunoglobulin and hepatitis C virus: an overview of transmission episodes with emphasis on manufacturing data

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41081020.X

Computerized comparison of six adverse drug reaction assessment procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41081020.X

Sequence variability of hepatitis A virus and factor VIII associated hepatitis A infections in hemophilia patients in Europe. An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41081020.X

10.1046/J.1537-2995.2001.41081020.X

21 January 2018

Identifiers

DOI

1 reference

15 December 2017

1 reference